Advertisement
Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer,will host a conference call to discuss the results and other corporatedevelopments at 10:30 AM ET on Thursday, November 8, 2007. Also participatingon the call will be Steven A. Shallcross, Senior Vice President and CFO. Toparticipate in the conference call, dial the appropriate number below shortlybefore the 10:30 AM start time and ask for the Vanda Pharmaceuticalsconference call hosted by Dr. Polymeropoulos.
Advertisement
The conference call will be broadcast simultaneously and archived on theCompany's Web site, www.vandapharma.com. Investors should go to the Web siteat least 15 minutes early to register, download, and install any necessaryaudio software.
A replay of the call will be available on Thursday, November 8, 2007,beginning at 12:30 PM ET and will be accessible until Thursday, November 15,2007, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domesticcallers and 1-617-801-6888 for international callers. The access number is60186931.
About Vanda Pharmaceuticals Inc.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on thedevelopment and commercialization of clinical-stage product candidates forcentral nervous system disorders. The company has three product candidates inclinical development. Vanda's lead product candidate, iloperidone, is acompound for the treatment of schizophrenia and bipolar disorder, and hasrecently submitted an NDA to the FDA for the treatment of schizophrenia.Vanda's second product candidate, VEC-162, is a compound for the treatment ofsleep and mood disorders which is currently in Phase III for sleep disorders.Vanda's third product candidate, VSF-173, is a compound for the treatment ofexcessive sleepiness in Phase II. For more on Vanda Pharmaceuticals Inc.,please visit http://www.vandapharma.com.The teleconference dial-in numbers are as follows: Domestic callers 1-866-578-5801 International callers 1-617-213-8058
SOURCE Vanda Pharmaceuticals Inc.
